The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geczy, C. L.
Right arrow Articles by Hopper, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geczy, C. L.
Right arrow Articles by Hopper, K. E.
Right arrowPubmed/NCBI databases
*Substance via MeSH

The Journal of Immunology, Vol 126, Issue 3 1059-1065, Copyright © 1981 by American Association of Immunologists


ARTICLES

A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro

CL Geczy and KE Hopper

Although lymphokine supernatants had no procoagulant activity per se, guinea pig peritoneal exudate cells (PEC), incubated with lymphokine supernatants or with a lymphokine fraction of 35,000 to 50,000 daltons decreased the recalcification time of platelet-poor plasma. PEC from animals immunized with BCG or with ovalbumin and incubated with the corresponding antigen had increased procoagulant activity. Similar effects were observed with PEC incubated with endotoxin. The induction of procoagulant activity by the cells was accompanied by a concomitant decrease in their ability to respond to chemotactic agents and to migrate from capillary tubes. Separation of exudate cells by sedimentation velocity indicated that large macrophages had the highest degree of procoagulant activity after incubation with lymphokines. The clotting time of Factor IX-deficient plasma was decreased by lymphokine- treated macrophages, indicating that the extrinsic clotting sequence may be activated as a result of increased tissue factor on the treated cells. Heparin abolished the ability of lymphokines to inhibit macrophage migration.


This article has been cited by other articles:


Home page
HeartHome page
N M Al-Saady, E W Leatham, S Gupta, J T C Kwan, J B Eastwood, and C A Seymour
Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure
Heart, February 1, 1999; 81(2): 134 - 140.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. T. Smiley, S. N. Boyer, M. J. Heeb, J. H. Griffin, and M. J. Grusby
Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity
PNAS, October 14, 1997; 94(21): 11484 - 11489.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1981 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1981 by The American Association of Immunologists, Inc. All rights reserved.